Short Interest in XPhyto Therapeutics Corp. (OTCMKTS:XPHYF) Grows By 33.3%

XPhyto Therapeutics Corp. (OTCMKTS:XPHYFGet Rating) was the target of a large increase in short interest in July. As of July 15th, there was short interest totalling 2,000 shares, an increase of 33.3% from the June 30th total of 1,500 shares. Based on an average trading volume of 1,600 shares, the short-interest ratio is currently 1.3 days.

XPhyto Therapeutics Price Performance

Shares of XPhyto Therapeutics stock opened at $0.35 on Monday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.42 and a current ratio of 0.55. The firm’s 50-day simple moving average is $0.47 and its 200-day simple moving average is $0.70. XPhyto Therapeutics has a twelve month low of $0.27 and a twelve month high of $1.60. The firm has a market cap of $28.14 million, a P/E ratio of -1.51 and a beta of -0.20.

About XPhyto Therapeutics

(Get Rating)

XPhyto Therapeutics Corp. operates as a bioscience company in Germany and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, such as depression, anxiety, addiction, and trauma-related stress disorder.

See Also

Receive News & Ratings for XPhyto Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPhyto Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.